Suhail Al-Salam Selected Research

Keratin-20 (Cytokeratin 20)

7/2009	Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in mucinous bronchioloalveolar adenocarcinoma after Hodgkin lymphoma.
10/2008	Malignant non-teratoid medulloepithelioma of ciliary body with retinoblastic differentiation: a case report and review of literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suhail Al-Salam Research Topics

Disease

23	Inflammation (Inflammations) 01/2024 - 09/2009
17	Neoplasms (Cancer) 03/2024 - 09/2006
9	Necrosis 03/2024 - 01/2010
7	Fibrosis (Cirrhosis) 01/2024 - 01/2018
6	Myocardial Infarction 01/2022 - 01/2013
6	Body Weight (Weight, Body) 01/2021 - 09/2008
5	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2010
5	Pneumonia (Pneumonitis) 02/2018 - 09/2009
5	Thrombosis (Thrombus) 01/2018 - 09/2009
5	Hodgkin Disease (Hodgkin's Disease) 11/2014 - 07/2009
4	Chronic Renal Insufficiency 01/2024 - 01/2014
4	Reperfusion Injury 01/2023 - 01/2018
4	Hypoxia (Hypoxemia) 02/2017 - 01/2012
3	Cardiotoxicity 05/2023 - 01/2019
3	Hypertension (High Blood Pressure) 02/2023 - 01/2018
3	Anaphylaxis (Anaphylactic Shock) 10/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 04/2021 - 09/2008
3	Epstein-Barr Virus Infections 01/2018 - 01/2013
3	Diabetes Mellitus 09/2011 - 01/2009
3	Type 2 Diabetes Mellitus (MODY) 09/2011 - 01/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 02/2023
2	Thrombophilia 02/2022 - 01/2017
2	Infarction (Infarctions) 01/2022 - 04/2020
2	Carcinoma (Carcinomatosis) 02/2019 - 05/2008
2	Lung Injury 01/2019 - 02/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014 - 02/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2013 - 03/2010
2	Wilms Tumor (Wilm's Tumor) 01/2012 - 05/2008
2	Adenocarcinoma 07/2009 - 10/2007
2	Neoplasm Metastasis (Metastasis) 09/2008 - 10/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2024
1	Hepatocellular Carcinoma (Hepatoma) 08/2023
1	Liver Neoplasms (Liver Cancer) 08/2023
1	Ischemia 01/2023
1	Shock 06/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2021

Drug/Important Bio-Agent (IBA)

10	Galectin 3 (LGALS3)IBA 03/2024 - 03/2009
10	SmokeIBA 01/2024 - 01/2017
8	Vehicle Emissions (Emissions, Vehicle)IBA 02/2018 - 09/2009
7	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2009
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2009
6	Adenine FDA LinkGeneric 01/2024 - 03/2010
6	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2018 - 09/2009
5	Gum Arabic (Acacia, Gum)FDA Link 01/2019 - 03/2010
4	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 03/2013
4	CytokinesIBA 01/2021 - 09/2008
4	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2012
3	EnzymesIBA 01/2024 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2018
3	nootkatoneIBA 01/2019 - 01/2018
2	AntioxidantsIBA 01/2024 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 08/2022
2	Fibrinogen (Factor I)FDA Link 02/2022 - 09/2011
2	Galectins (Galectin)IBA 06/2021 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2019
2	ceric oxide (cerium dioxide)IBA 01/2019 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2019
2	gamma-Aminobutyric Acid (GABA)IBA 01/2015 - 01/2009
2	Galectin 1 (LGALS1)IBA 01/2014 - 08/2011
2	Caspase 3 (Caspase-3)IBA 10/2013 - 08/2011
2	ParaffinIBA 09/2009 - 01/2009
2	Carcinoembryonic AntigenIBA 07/2009 - 10/2008
2	Calbindin 2IBA 07/2009 - 10/2008
2	Keratin-7 (Cytokeratin 7)IBA 07/2009 - 10/2008
2	Keratin-20 (Cytokeratin 20)IBA 07/2009 - 10/2008
2	Mucin-1 (CA 15-3 Antigen)IBA 07/2009 - 10/2008
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2009 - 10/2008
2	Keratins (Keratin)IBA 10/2008 - 09/2006
1	PlatinumIBA 03/2024
1	Atrial Natriuretic Factor (ANF)IBA 01/2024
1	CateninsIBA 08/2023
1	Sorafenib (BAY 43-9006)FDA Link 08/2023
1	crocinIBA 08/2023
1	Therapeutic UsesIBA 08/2023
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2023
1	SilverIBA 05/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	nerolidolIBA 01/2023
1	catalpolIBA 01/2023
1	TM 1IBA 10/2022
1	LyasesIBA 10/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2022
1	4-Aminopyridine (4 Aminopyridine)FDA Link 10/2022
1	CystathionineIBA 10/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2022
1	Thromboplastin (Tissue Factor)IBA 02/2022
1	CathepsinsIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2021
1	Lactate Dehydrogenase 5IBA 04/2021
1	Voltage-Dependent Anion ChannelsIBA 04/2021
1	SodiumIBA 04/2021

Therapy/Procedure

6	Therapeutics 08/2023 - 09/2008
3	Pancreatectomy 09/2011 - 01/2009
2	Ligation 01/2022 - 04/2020
2	Drug Therapy (Chemotherapy) 02/2019 - 07/2009
2	Colectomy 01/2019 - 06/2016
2	Immunotherapy 01/2013 - 09/2008